Literature DB >> 10708059

Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis.

R Wood1, G Maartens, C J Lombard.   

Abstract

OBJECTIVE: To estimate the incidence rate of tuberculosis in HIV-1-infected adults resident in a region with a high tuberculosis prevalence and to identify clinical and laboratory parameters associated with increased risk of developing tuberculosis.
METHODS: Adult patients going to the University of Cape Town HIV clinics between January 1986 and May 1996. The following variables were assessed for the risk of developing tuberculosis: ethnicity, employment and education status, World Health Organization (WHO) clinical stage, erythrocyte sedimentation rate (ESR), CD4+ count, and total lymphocyte count. Tuberculin skin test data were not available.
RESULTS: There were 198 prevalent and 144 incident cases of tuberculosis in the cohort of 1206 patients. The incidence rate of tuberculosis risk was 10.4/100 person years. WHO clinical stages 3 and 4 (risk ratio [RR], 3.4; 95% confidence interval [CI], 1.8-6.4), ESR >75 mm/hour (RR, 3.5; CI, 1.8-6.5) and being a member of a high-prevalence tuberculosis community (RR, 2.5; CI, 1.2-5.1) were independently associated with the risk of developing tuberculosis.
CONCLUSIONS: HIV-infected adults in Cape Town are at high risk of developing tuberculosis irrespective of tuberculin skin testing. The risk increases markedly with HIV disease progression. Patients at extremely high risk can be identified on the basis of demographic and clinical features. Such individuals would be suitable for targeted tuberculosis prophylaxis.

Entities:  

Mesh:

Year:  2000        PMID: 10708059     DOI: 10.1097/00126334-200001010-00010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  35 in total

1.  Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control.

Authors:  Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

2.  Disease progression among untreated HIV-infected patients in South Ethiopia: implications for patient care.

Authors:  Degu Jerene; Bernt Lindtjørn
Journal:  MedGenMed       Date:  2005-08-30

3.  Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district.

Authors:  D Nansera; F Bajunirwe; J Kabakyenga; P K J Asiimwe; H Mayanja-Kizza
Journal:  Afr Health Sci       Date:  2010-12       Impact factor: 0.927

4.  Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis.

Authors:  Claudia C Dobler; Kelvin Cheung; John Nguyen; Andrew Martin
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

5.  Risk of tuberculosis among HAART receiving HIV patients attending an ART centre of West Bengal, India: a prospective cohort study.

Authors:  Rajib Saha; Indranil Saha
Journal:  J Community Health       Date:  2014-10

6.  Detailed epidemiological analysis as a strategy for evaluating the actual behavior of tuberculosis in an apparently low-incidence region.

Authors:  Ana Laura Guillén-Nepita; Gerardo Vázquez-Marrufo; Andrés Cruz-Hernández; Felipe García-Oliva; Reyna Cristina Zepeda-Gurrola; Ma Soledad Vázquez-Garcidueñas
Journal:  Pathog Glob Health       Date:  2020-09-14       Impact factor: 2.894

7.  Tuberculous disseminated lymphadenopathy in an immunocompetent non-HIV patient: a case report.

Authors:  Irini Gerogianni; Maria Papala; Konstantinos Kostikas; Maria Ioannou; Argiroula-Vasiliki Karadonta; Konstantinos Gourgoulianis
Journal:  J Med Case Rep       Date:  2009-12-03

8.  Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis.

Authors:  Timothy Lahey; Mecky Matee; Lillian Mtei; Muhammad Bakari; Kisali Pallangyo; C Fordham von Reyn
Journal:  BMC Infect Dis       Date:  2009-02-23       Impact factor: 3.090

9.  Disease Progression Among Untreated HIV-Infected Patients in South Ethiopia: Implications for Patient Care.

Authors:  Degu Jerene; Bernt Lindtjørn
Journal:  J Int AIDS Soc       Date:  2005-08-30       Impact factor: 5.396

10.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.